Atherosclerosis and Heart Disease

ISBN-13: 9781841841236 / Angielski / Twarda / 2003 / 256 str.

Freek Verheugt; Andrew Tonkin; Tonkin Tonkin

Opis

The identification of cholesterol as a possible risk factor for coronary heart disease was first made after it was recognized that in countries with a high mean blood cholesterol, the mortality from coronary heart disease was also high. Lowering cholesterol levels helps to reduce the chances of myocardial infarction and certain types of stroke. Andrew Tonkin and his team of internationally recognized experts present the reader with sound clinical practices, based on scientific research and publications.

Spis treści

Pathophysiology of Atherosclerotic Heart Disease, J. Plutzky and P. Libby
Blood Pressure and Blood Pressure-Lowering Therapy, B. Neal
Lipds and Lipid-Modifying Therapy, A. Gaw, C.J. Packard, and J. Shepherd
Novel Atherosclerotic Risk Factors and Management, K.S. Woo and D. Magliano
Diabetes and the Heart, D.J. Betteridge
Management of ST Elevation Myocardial Infarction, J. Lopez-Sendon, E. Lopez de Sa, and J.J. Gomez de Diego
Risk Assessment in Patients with Non-ST Elevation Acute Coronary Syndromes, H.D. White
Management of Unstable Angina and Non-ST Elevation Myocardial Infarction, P. Fasseas, A.E. Denktas, and P.B. Berger
Medical Management of Angina Pectoris, J.D. Horowitz
New Devices in Interventional Cardiology and Atherosclerotic Disease, E. Regar, C.H. Lee, J.A. Schaar, P.A. Lemos, and P.W. Serruys
Coronary Artery Bypass Surgery, B. Buxton and S. Seevanayagam
The Contemporary Management of Heart Failure, N. Sharpe and R. Doughty
Treatment of Ventricular Arrhythmias, A.-Y. Chong and G.Y.H. Lip
Atrial Fibrillation and Stroke Prevention, G.J. Hankey
Future Challenges, A.M. Tonkin

O autorze

Andrew M Tonkin, MD, FRACP
Adjunct Professor
NHMRC Clinical Research Centre of Excellence in therapeutics
department of Epidemiology and Preventative Medicine
Monash University
Australia